Global Research on Appearance in Cancer (GRACE)

Changes in Body Composition After EPA Supplementation in Head and Neck Patients

NCT02715596 ·Status: COMPLETED ·Phase: PHASE3

Self-Care for Head and Neck Cancer Survivors With Lymphedema and Fibrosis

NCT03030859 ·Status: COMPLETED ·Phase: NA

Nutritional Status of Head and Neck Cancer Patients

NCT07068711 ·Status: RECRUITING

Optimised Early Management of Squamous Cell Carcinoma of the Head and Neck Cancer

NCT04528420 ·Status: RECRUITING ·Phase: NA

A Study of MEHD7945A in Combination With Cisplatin and 5-Fluorouracil (5-FU) or Paclitaxel and Carboplatin in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN)

NCT01911598 ·Status: COMPLETED ·Phase: PHASE1

Impact of Secondary Lymphedema on Symptoms, Functional Status, and Quality of Life After Treatment in Patients With Head and Neck Cancer

NCT01098669 ·Status: COMPLETED

Biomedical Innovation for Facial Bone Reconstruction in Oncology: BIOFACE PASS a Medico-economic Study Describing the Standard Pathway of Patients Treated by Free Bone Flap

NCT06771336 ·Status: RECRUITING

A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)

NCT06525220 ·Status: RECRUITING ·Phase: PHASE3

Randomized Phase II Study of DCE-MRI-based Dose Escalation for Poor-prognosis and Neck Cancer

NCT02031250 ·Status: COMPLETED ·Phase: PHASE2

Chemotherapy With Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

NCT01289522 ·Status: COMPLETED ·Phase: PHASE2

Definitive Chemo-Radiotherapy for Regionally Advanced Head and Neck Cancer With or Without Up-front Neck Dissection

NCT02918955 ·Status: COMPLETED ·Phase: PHASE3

Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma

NCT01154920 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Impact of Low Muscle Mass in HNC Treated With Immunotherapy

NCT04721184 ·Status: UNKNOWN

Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck Cancer

NCT00176241 ·Status: TERMINATED ·Phase: PHASE1

Building a Renewed ImaGe After Head & Neck Cancer Treatment (BRIGHT) 2.0

NCT03831100 ·Status: COMPLETED ·Phase: NA

Observational Study on Biomarkers in Head and Neck Cancer (HNprädBio)

NCT02059668 ·Status: COMPLETED

De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up Study

NCT02281955 ·Status: COMPLETED ·Phase: PHASE2

Customized Registry Tool for Tracking Adherence to Clinical Guidelines for Head and Neck Cancers

NCT03546322 ·Status: COMPLETED

Study to Evaluate the Safety and Efficacy of Oral NRC-2694-A in Combination With Paclitaxel in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma, Who Progressed on or After Immune Checkpoint Inhibitor Therapy

NCT05283226 ·Status: RECRUITING ·Phase: PHASE2

Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck Cancers

NCT04747054 ·Status: RECRUITING ·Phase: PHASE3

High-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer

NCT00002555 ·Status: COMPLETED ·Phase: PHASE3

[68Ga]Ga-FAPI-46 in Staging of Head and Neck Carcinomas

NCT06794372 ·Status: RECRUITING ·Phase: PHASE2

Anti-tumor Specific Immune Response in Head and Neck Cancers

NCT02881918 ·Status: UNKNOWN

Late Phase II Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced or Recurrent Head and Neck Cancer

NCT00855764 ·Status: COMPLETED ·Phase: PHASE2

Bortezomib, Cetuximab, and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage IV Head and Neck Cancer

NCT00629226 ·Status: COMPLETED ·Phase: PHASE1